HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Post-Surgery Tissue Monitoring and Diagnostic System Detects Anastomotic Leaks after GI Surgery

By HospiMedica International staff writers
Posted on 25 Mar 2022
Print article
Image: xBar is a sensor designed to track tissue healing internally from the surgical site following an operation (Photo courtesy of Unsplash)
Image: xBar is a sensor designed to track tissue healing internally from the surgical site following an operation (Photo courtesy of Unsplash)

Anastomotic (AI) leak is a common, life threatening complication of gastrointestinal (GI) surgeries such as colorectal and bariatric. Early detection before clinical manifestation of AI leak is key to a favorable outcome, but diagnosis at this stage is difficult. Now, a tissue monitoring and diagnostic system is being studied for the early detection of AI leaks following low anterior resection GI surgery.

Exero Medical’s (Or Yehuda, Israel) xBar tissue monitoring and diagnostic system is a sensor designed to track tissue healing internally from the surgical site following an operation. The biodegradable wireless sensor aims to prevent complications by warning physicians of a potential leak, enabling early intervention. Exero’s system intended benefits are better patient recovery, prevention of serious complications in case of a postoperative leak, generation of new real time data on patient recovery, cost reduction and shorter hospitalization.

Exero has enrolled the first patient in its multi-center safety and feasibility study of xBar. The data collected will be used to refine the system's machine-learning algorithms and evaluate the system against the institutional standard of leak diagnosis. Exero’s system targets an addressable market of millions of procedures annually with over USD 2 billion of potential revenues.

"An anastomotic leak is the most fretted complication of colorectal surgery. Of the more than five million patients undergoing GI surgery every year, as many as 10% percent could develop this devastating complication," said Professor Nir Wasserberg, M.D., Chair of the Israel Colorectal Society and Director, Division of Colorectal Surgery, Department of Surgery, Beilinson Campus, Rabin Medical Center. "Of those, up to 40%, will need multiple revision surgeries, longer hospitalization stays in terms of weeks and, frankly some won't make it. Mortality depends on how early a leak is detected and how quickly intervention begins. The diagnostic monitoring system developed by Exero Medical is intended to provide timely intervention that could save lives and improve the prognosis of hundreds of thousands of patients as well as save the healthcare system billions of dollars every year."

"The severe complications associated with AI leaks cost the healthcare system in excess of USD 7 billion annually," said Exero Medical CEO Dr. Erez Shor. "It's important to understand that these complications can be avoided by detecting such leaks early. Exero Medical's breakthrough technology is designed to directly monitor the healing of the surgical site so that post-op complications can be circumvented."

Related Links:
Exero Medical 

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Needle-Free IV Connector Technology
Clave
New
Automated Cough Assist Device
Bionic Cough Simulator

Print article

Channels

Critical Care

view channel
Image: The Atmo Gas Capsule measures gases as it travels through the GI tract and transmits the data wirelessly (Photo courtesy of Atmo Biosciences)

Ingestible Smart Capsule for Chemical Sensing in the Gut Moves Closer to Market

Intestinal gases are associated with several health conditions, including colon cancer, irritable bowel syndrome, and inflammatory bowel disease, and they have the potential to serve as crucial biomarkers... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more